GovWire

Decision: Regulatory approval of Spikevax bivalent Original/Omicron booster vaccines

Medicines Healthcare Products Regulatory Agency

January 19
11:23 2024

Last updated 15/9/23 - Summary of Product Characteristics Spikevax bivalent BA.1 Original/Omicron

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email webupdates@mhra.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Last updated 15/9/23 - Patient Information Leaflet Spikevax bivalent BA.1 Original/Omicron

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email webupdates@mhra.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Spikevax bivalent Original/Omicron Information for Healthcare Professionals (Regulation 174)

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email webupdates@mhra.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Spikevax bivalent Original/Omicron Patient Information Leaflet (Regulation 174)

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email

Related Articles

Comments

  1. We don't have any comments for this article yet. Why not join in and start a discussion.

Write a Comment

Your name:
Your email:
Comments:

Post my comment

Recent Comments

Follow Us on Twitter

Share This


Enjoyed this? Why not share it with others if you've found it useful by using one of the tools below: